CCEL

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.05
Percentage change -0.96	%

Peers: CYRX VERU KRYS COOP KOD MRNS ARCT

Scroll to Statements

Index	-	P/E	404.00	EPS (ttm)	0.01	Insider Own	50.43%	Shs Outstand	8.08M	Perf Week	-7.00%
Market Cap	40.81M	Forward P/E	-	EPS next Y	-0.04	Insider Trans	0.00%	Shs Float	4.01M	Perf Month	0.06%
Enterprise Value	51.19M	PEG	-	EPS next Q	-0.04	Inst Own	7.68%	Short Float	0.19%	Perf Quarter	-19.20%
Income	0.13M	P/S	1.27	EPS this Y	-220.00%	Inst Trans	-0.08%	Short Ratio	0.60	Perf Half Y	-31.76%
Sales	32.10M	P/B	-	EPS next Y	33.33%	ROA	0.20%	Short Interest	0.01M	Perf YTD	-31.85%
Book/sh	-1.81	P/C	11.73	EPS next 5Y	-	ROE	-	52W High	9.43 -46.45%	Perf Year	-33.64%
Cash/sh	0.43	P/FCF	7.69	EPS past 3/5Y	-41.85% -29.04%	ROIC	-	52W Low	4.75 6.32%	Perf 3Y	-9.05%
Dividend Est.	-	EV/EBITDA	9.79	Sales past 3/5Y	3.46% 0.11%	Gross Margin	73.79%	Volatility	5.07% 5.49%	Perf 5Y	-11.50%
Dividend TTM	0.65 (12.87%)	EV/Sales	1.59	EPS Y/Y TTM	101.38%	Oper. Margin	12.56%	ATR (14)	0.28	Perf 10Y	199.61%
Dividend Ex-Date	May 21, 2025	Quick Ratio	0.54	Sales Y/Y TTM	2.33%	Profit Margin	0.40%	RSI (14)	46.84	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.58	EPS Q/Q	-48.35%	SMA20	-1.86%	Beta	0.64	Target Price	8.50
Payout	510.20%	Debt/Eq	-	Sales Q/Q	1.49%	SMA50	-1.24%	Rel Volume	0.56	Prev Close	5.10
Employees	82	LT Debt/Eq	-	Earnings	Apr 15 BMO	SMA200	-24.09%	Avg Volume	12.35K	Price	5.05
IPO	Apr 04, 1994	Option/Short	No / Yes	EPS/Sales Surpr.	200.00% 0.89%	Trades		Volume	6,885	Change	-0.96%

May-08-25 05:00PM	Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend (Business Wire)
Apr-16-25 11:59AM	Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz (TipRanks) +9.48%
Apr-15-25 08:30AM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results (Business Wire)
Jan-29-25 04:15PM	Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives (Business Wire)
Oct-30-24 08:45AM	Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend (Business Wire) +25.60%
05:20PM	Loading…
Oct-15-24 05:20PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results (Business Wire) +6.98%
Jul-15-24 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results (Business Wire) -6.07%
Apr-15-24 05:00PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results (Business Wire) -5.37%
Mar-25-24 09:00AM	Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value (Business Wire) +7.64%
Feb-28-24 05:00PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 (Business Wire)
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Oct-12-23 04:45PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results (Business Wire)
Jul-14-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results (Business Wire) -9.50%
Apr-21-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results (Business Wire) +14.74%
Feb-28-23 05:15PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022 (GlobeNewswire)
11:00AM	Loading…
Jan-24-23 11:00AM	Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET (GlobeNewswire)
Oct-14-22 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results (GlobeNewswire)
Aug-22-22 06:00PM	Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend (GlobeNewswire) +15.38%
Aug-17-22 05:00PM	Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange (GlobeNewswire) +10.36% -7.65%
Jul-11-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results (GlobeNewswire)
Apr-13-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results (GlobeNewswire)
Mar-16-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service (GlobeNewswire)
Mar-09-22 04:15PM	Cryo-Cell Shares Its 2021 Annual Letter to Shareholders (GlobeNewswire)
Feb-22-22 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021 (GlobeNewswire) +7.00% -10.03%
Oct-27-21 04:15PM	Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials (GlobeNewswire)
Oct-15-21 04:36PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results (GlobeNewswire)
Sep-20-21 06:05PM	Cryo-Cell International Announces Changes To Its Board of Directors (GlobeNewswire) -5.45% +6.51%
Aug-30-21 09:00AM	Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market (GlobeNewswire) +7.82%
Aug-20-21 09:04AM	Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies (GlobeNewswire)
Aug-11-21 12:03PM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021 (Newsfile)
09:00AM	Loading…
09:00AM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit (GlobeNewswire)
Jul-15-21 07:27PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results (GlobeNewswire)
May-10-21 09:00AM	Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials (GlobeNewswire)
Apr-14-21 06:14PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results (GlobeNewswire)
Feb-26-21 09:30AM	Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University (GlobeNewswire) +11.11%
Feb-24-21 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2020 (GlobeNewswire)
Oct-15-20 04:39PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial Results (GlobeNewswire)

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mikulinsky Oleg	Chief Information Officer	Nov 12 '24	Option Exercise	3.77	20,000	75,400	104,349	Nov 14 05:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Cryo-Cell International, Inc

Upgrade your FINVIZ experience